Advertisement Novartis chooses Veeva CRM for global deployments - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Novartis chooses Veeva CRM for global deployments

Novartis Pharmaceuticals has selected Veeva CRM suite of applications for various global deployments.

The Veeva CRM suite of applications includes VBioPharma, VMobile and VInsights.

VBioPharma offers multiple editions in one CRM product to accommodate the unique needs of various life sciences commercial teams. It comes pre-validated for PDMA and CFR Part 11 compliance, Veeva said.

The company claims that the complete Veeva CRM suite gives customers the mobility and reporting solutions needed to drive user adoption and sales effectiveness.

According to Veeva, because of its multi-tenant SaaS architecture, the CRM solution requires no hardware or software to purchase, scale, or maintain.

Veeva Systems is a provider of multi-tenant SaaS-based solutions for the global life sciences industry.